- Reduced Risk of Dying in Women With DCIS
Reduced Risk of Dying in Women With DCIS
Bottom Line: Lumpectomy plus radiation was associated with a small clinical benefit in reduced risk of breast cancer death compared with lumpectomy or mastectomy alone in women with ductal carcinoma in situ (DCIS), a noninvasive early form of breast cancer.
Why The Research Is Interesting: Patients with DCIS are often treated with radiation after lumpectomy, although it has remained unclear whether this can reduce the risk of dying from breast cancer.
Who and When: More than 140,000 U.S. women who had DCIS between 1998 and 2014; this study compared lumpectomy plus radiation vs. lumpectomy alone, lumpectomy vs. mastectomy, and lumpectomy plus radiation vs. mastectomy
What (Study Measures and Outcomes): Use of radiation and/or extent of surgery (exposures); breast cancer mortality rates within 15 years (outcomes)
How (Study Design): This was an observational study. Researchers were not intervening for purposes of the study and cannot control all the natural differences that could explain the study findings.
Authors: Steven A. Narod, M.D., of Women’s College Research Institute, in Ontario, Canada, and co-authors
Results: A small improvement in breast cancer survival was associated with radiation plus lumpectomy for DCIS. The absolute risk reduction was 0.27 percent, making it necessary to treat 370 women to save one life. Patients who had lumpectomy plus radiation had more local recurrences than the mastectomy patients but had fewer deaths.
Study Limitations: Some data were missing; investigators didn’t have information on tamoxifen use; treatments in the study population weren’t randomly assigned; and the possibility remains that the decision to undergo radiotherapy was associated with other favorable prognostic factors.
Among patients with DCIS, treatment with lumpectomy and radiotherapy is associated with a significant reduction in breast cancer mortality compared with either lumpectomy alone or mastectomy. Although the clinical benefit is small, it is intriguing that radiotherapy has this effect, which appears to be attributable to systemic activity rather than local control. How exactly radiotherapy affects survival is an important question that should be explored in future studies.
Related Material: The invited commentary, “Systemic Effects of Radiotherapy in Ductal Carcinoma In Situ,” by Mira Goldberg, M.D., and Timothy J. Whelan, B.M., B.Ch., of McMaster University, Ontario, Canada, also is available on the For The Media website.
To Learn More: The full study is available on the For The Media website.
DISCLAIMER: Bankix Systems Ltd is the registered name of a Canadian firm since 2003, and bankixsystems.com is its OFFICIAL website. Besides these entities, we have no relationship with anyone, business, website, or any other entity anywhere in the world, claiming to be Bankix Systems, or using a similar name, and creating the impression that it has some connection with our company. We do not endorse and are therefore, not responsible for any act or lack thereof by any such entity. Bankix Systems Ltd is also not responsible for the content of the description of products and services linked to our site nor does it necessarily endorse them. The information here provided is not for diagnosing/treating your health concerns. Kindly contact your doctor or health care professional for all your healthcare requirements.
Contents © 2003-2019, BankixSystems.com. All rights reserved. Unauthorized reproduction strictly prohibited. Information based on best available resources. Opinions are current and subject to change.